Sichuan Huiyu Pharmaceutical Co., Ltd. (SHA:688553)
China flag China · Delayed Price · Currency is CNY
16.59
-0.06 (-0.36%)
Jun 16, 2025, 2:45 PM CST

Sichuan Huiyu Pharmaceutical Company Description

Sichuan Huiyu Pharmaceutical Co., Ltd. research and develops, produces, and sells anti-tumor and injection drugs in China and internationally.

The company offers injection drug products, such as pemetrexed disodium, methrotraxate, docetaxel, azacitidine, oxaliplatin, irinotecan hydrochloride, paclitaxel, bendamustine hydrochloride, palonosetron hydrochloride, plerixafor, levetiracetam concentrated solution, sodium valproate concentrated solution, epirubicin hydrochloride, fulvestrant, milrinone, fluorouracil, sodium thiosulfate, zoledronic acid, zoledronic acid concentrated solution, cisatracurium besylate, bortezomib, octreotide acetate, doxorubicin, and palonosetron hydrochloride.

Sichuan Huiyu Pharmaceutical Co., Ltd. was incorportaed in 2010 and is headquartered in Neijiang, China.

Sichuan Huiyu Pharmaceutical Co., Ltd.
Country China
Founded 2010
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 1,382
CEO Zhao Ding

Contact Details

Address:
Building 3
Neijiang, 641000
China
Phone 86 83 2880 8001
Website huiyupharma.com

Stock Details

Ticker Symbol 688553
Exchange Shanghai Stock Exchange
Fiscal Year January - December
Reporting Currency CNY
ISIN Number CNE100004ZT4
SIC Code 2834

Key Executives

Name Position
Dr. Zhao Ding Chairman of the Board and GM
Gang Cai Manager of Technical Department, Quality Manager and Quality Director